Central Portalization Correlates with Fibrosis but Not with Risk Factors for Nonalcoholic Steatohepatitis in Steatotic Chronic Hepatitis C

Table 2

Clinical parameters versus fibrosis, steatosis, and nonalcoholic fatty liver disease (NAFLD) activity score [36] in the study group by Student’s -test. Present: with the clinical parameter; absent: without the clinical parameter; Ishak: Ishak’s fibrosis staging system [35]; ^∗statistically significant (); type 2 DM: type 2 diabetes mellitus.

	Clinical parameter	Present	Absent	value
Fibrosis (Ishak)	Obesity	2.9	3.9
	Type 2 DM	3.3	3.3
	Alcohol	3.6	3.0
Steatosis (%)	Obesity	56%	45%
	Type 2 DM	49%	50%
	HCV genotype 3	50%	48%
NAFLD activity score	Obesity	5.3	4.7
	Type 2 DM	4.9	5.0
	Hyperlipidemia	5.8	4.9
	Alcohol	4.8	5.2